Portal de Periódicos da CAPES

Lateral interbody fusion for adjacent segment disease: a narrative review

2024; AME Publishing Company; Volume: 10; Issue: 2 Linguagem: Inglês

10.21037/jss-23-16

2414-469X

Christopher L. Antonacci, Francine Zeng, Casey Jackson, Ian J. Wellington, Seema Patel, Sean Esmende,

Nail Diseases and Treatments

Adjacent segment disease (ASD) is a late complication of lumbar fusion characterized by persistent symptoms correlating to radiographic changes in the levels immediately above or below the prior fusion. Lateral interbody fusion (LIF) through a direct lateral approach is a minimally invasive and effective surgical treatment for ASD. Biomechanically, LIF for ASD provides significantly decreased motion in multiple planes. While hardware failure and injury to the lumbar plexus are potential complications, these risks may be outweighed by decreased blood loss, shorter operating room (OR) times, and possibly superior patient reported visual analog scale (VAS) scores compared to traditional posterior spinal fusion (PSF) alone. The purpose of this review is to summarize the history, uses, outcomes, and future directions of LIF for ASD.